Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 381 results found. Search for [ drug patent ]

Results 1 to 21 of 381
Joe C Mathew and Nidhi Singal
New Delhi, April 14, 2021
The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


BusinessToday.In
March 20, 2021
NPPA, with this price regulation, has re-assured the availability of medicines at fair prices to the public


Joe C Mathew
New Delhi, December 24, 2020
Premchand Godha's strategy for IPCA has not changed, it's about being integrated and focusSING on profitability


Joe C Mathew
New Delhi, December 9, 2020
Centre has announced two schemes to reduce import dependence in medicine manufacturing. Will they work this time?


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


BusinessToday.In
November 18, 2020
Stocks to watch today on November 18: Lakshmi Vilas Bank, DLF, Tanla Platforms and  Eveready Industries among others are the top stocks to watch out for in Wednesday's trading session


BusinessToday.In
November 17, 2020
Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week


BusinessToday.In
November 13, 2020
Dalal Street today: IndusInd Bank, followed by SBI, L&T, Axis Bank, HDFC twins, Kotak Bank and ICICI Bank were among the top losers today. On the other hand, Asian Paints, Reliance Industries, Titan, Bajaj Finance and Sun Pharma were trading with gains


BusinessToday.In
October 30, 2020
India Stock Market Highlights Today: Global equities were buoyed today amid upbeat domestic economic data and rally in stocks in anticipation of better earnings reports


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


Joe C Mathew
October 13, 2020
In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route


PB Jayakumar
October 8, 2020
Cipla's research and development department is working on a couple of therapies that can be used in the treatment of COVID-19 and it could consider entering into marketing collaborations with companies that are currently developing vaccines for COVID-19


Reuters
October 8, 2020
Several European countries have said they are experiencing shortages of the drug, whose global stock has been secured almost entirely by the United States


BusinessToday.In
October 7, 2020
Prime Minister Narendra Modi on Wednesday entered his 20th consecutive year as head of the democratically elected government


Reuters
October 7, 2020
The FDA released the guidance laying out more stringent recommendations for drugmakers hoping to apply for an emergency use authorization (EUA) for their experimental vaccines


Joe C Mathew
October 7, 2020
Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir


BusinessToday.In
September 17, 2020
As part of the settlement, Celgene has agreed to provide Dr Reddy's with a licence to sell volume-limited amounts of generic lenalidomide capsules in the US after March 2022 subject to regulatory approval


PTI
August 17, 2020
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)


PAGES 1 OF 20  12345